|
CAA
MCID: AMY012
|
Amyloidosis Cerebral malady |
|
Sources: 17Genetics Home Reference, 22MalaCards See all sources Export this MalaCard |
Genetics Home Reference: Hereditary cerebral amyloid angiopathy is a condition that can cause a progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Due to neurological decline, this condition is typically fatal in one's sixties, although there is variation depending on the severity of the signs and symptoms. Most affected individuals die within a decade after signs and symptoms first appear, although some people with the disease have survived longer.17
MalaCards: Amyloidosis Cerebral, also known as senile cerebral amyloid angiopathy, is related to cerebral amyloid angiopathy, dutch, italian, iowa, flemish, arctic variants and arteriosclerosis. An important gene associated with Amyloidosis Cerebral is APP (amyloid beta (A4) precursor protein). The drugs acetylcysteine and colchicine have been mentioned in the context of this disorder. |
|
Sources: 30NIH Rare Diseases, 43UMLS See all sources |
|
Sources: 13GeneCards, 14GeneDecks See all sources |
Diseases related to amyloidosis cerebral by text searches and GeneDecks gene sharing:(show all 16)
Graphical network of the top 20 diseases related to amyloidosis cerebral: |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for amyloidosis cerebral Drug clinical trials:Search ClinicalTrials for amyloidosis cerebral Search NIH Clinical Center for amyloidosis cerebral Search CenterWatch for amyloidosis cerebral Inferred drug relations via UMLS/NDF-RT:43 28 acetylcysteine, colchcine, colchicine |
|
|
|
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
